WST - West Pharmaceutical Services - Stock & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9553061055
Stoppers, Seals, Syringe Components, Films, Coatings, Containers, Injectors
West Pharmaceutical Services, Inc. is a leading global provider of innovative solutions for the pharmaceutical, biotechnology, and medical device industries. The company designs, manufactures, and sells a wide range of containment and delivery systems for injectable drugs and healthcare products, serving customers across the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
The company operates through two primary segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment is focused on developing and supplying high-quality components and systems for injectable drug packaging, including stoppers, seals, syringe and cartridge components, and advanced administration systems. These solutions are designed to enhance the safe delivery of drugs and improve patient outcomes. The segment also offers a range of integrated services, such as analytical lab services, regulatory expertise, and after-sales technical support, to support pharmaceutical and biotechnology companies in the development and commercialization of their products.
In addition to its proprietary products, West Pharmaceutical Services, Inc. also provides contract manufacturing services for devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment leverages the company's expertise in design, manufacturing, and automated assembly to deliver high-quality devices to its customers.
With a strong commitment to innovation and customer satisfaction, West Pharmaceutical Services, Inc. has established a global sales and distribution network, with a team of experienced sales professionals, contract sales agents, and regional distributors. The company's website, https://www.westpharma.com, provides customers with easy access to product information, technical support, and other resources.
Founded in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania, and has a long history of delivering innovative solutions to the pharmaceutical and healthcare industries. Today, the company is a trusted partner to many leading pharmaceutical, biotechnology, and medical device companies, and continues to invest in research and development to stay at the forefront of the industry.
Drawdown (Underwater) Chart
WST Stock Overview
Market Cap in USD | 20,779m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC SubIndustry | Health Care Supplies |
TER | 0.00% |
IPO / Inception | 1978-01-13 |
WST Stock Ratings
Growth 5y | 38.9 |
Fundamental | 55.7 |
Dividend | 44.2 |
Rel. Performance vs Sector | -2.39 |
Analysts | 4.00/5 |
Fair Price Momentum | 339.42 USD |
Fair Price DCF | 122.81 USD |
WST Dividends
Dividend Yield 12m | 0.26% |
Yield on Cost 5y | 0.56% |
Dividends CAGR 5y | 4.77% |
Payout Consistency | 96.4% |
WST Growth Ratios
Growth Correlation 3m | -17.3% |
Growth Correlation 12m | -66.9% |
Growth Correlation 5y | 48.1% |
CAGR 5y | 16.89% |
CAGR/Mean DD 5y | 0.92 |
Sharpe Ratio 12m | -0.01 |
Alpha vs SP500 12m | -40.96 |
Beta vs SP500 5y weekly | 0.91 |
ValueRay RSI | 79.83 |
Volatility GJR Garch 1y | 29.95% |
Price / SMA 50 | 3.32% |
Price / SMA 200 | -8.04% |
Current Volume | 764.3k |
Average Volume 20d | 771.6k |
External Links for WST Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of October 29, 2024, the stock is trading at USD 310.41 with a total of 764,274 shares traded.
Over the past week, the price has changed by +8.06%, over one month by -0.19%, over three months by +7.81% and over the past year by -2.25%.
According to ValueRays Forecast Model, WST West Pharmaceutical Services will be worth about 375.4 in October 2025. The stock is currently trading at 310.41. This means that the stock has a potential upside of +20.95%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 343.5 | 10.6 |
Analysts Target Price | 400.7 | 29.1 |
ValueRay Target Price | 375.4 | 20.9 |